Genesis IBRC P/E Ratio
Genesis IBRC P/E ratio. Genesis IBRC (GENESIS) P/E ratio is not applicable — EPS (TTM) ₹-0.03. See Healthcare peers with valid P/E ratios below.
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
No recent earnings data available.
Current EPS: ₹-0.03
Healthcare Peers with Valid P/E Ratios — GENESIS Comparison
Healthcare sector average P/E 56.36, median 32.41 — GENESIS excluded (negative EPS).
Sector Average PE
56.36
Sector Median PE
32.41
Lowest PE
2.04
Profitable Companies
200
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 2.04 | ₹65 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.41 | ₹63 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.29 | ₹6,582 | Low |
| Dipna Pharmachem | DPL | 4.57 | ₹12 | Low |
| JFL Life Sciences | JFLLIFE | 4.88 | ₹66 | Low |
| Kabra Drugs | KABRADG | 6.09 | ₹44 | Low |
| GKB Ophthalmics | GKB | 6.27 | ₹33 | Low |
| Royal Sense | ROYAL | 6.58 | ₹47 | Low |
| Colinz Laboratories | COLINZ | 6.62 | ₹18 | Low |
Related Analysis
- For live price, revenue and the complete fundamental profile, see GENESIS stock price BSE.
- Check GENESIS market cap trends to track the company's total market size over time.
- Also explore GENESIS price trends to track price trends across different timeframes.